These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10832150)

  • 1. [Out-of- or in-hospital occurrences of malignant ventricular tachyarrhythmias: the prognostic significance in the population enrolled in the AVID study. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):579-80. PubMed ID: 10832150
    [No Abstract]   [Full Text] [Related]  

  • 2. [The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):577-8. PubMed ID: 10832149
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable ventricular tachycardia is not a benign rhythm: insights from the AVID registry. Antiarrhythmics versus Implantable Defibrillators.
    Indian Heart J; 2001; 53(3):377. PubMed ID: 11547738
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of malignant ventricular tachyarrhythmias.
    Gomes JA; Winters SL; Ergin A
    Mt Sinai J Med; 1992 Sep; 59(4):318-25. PubMed ID: 1406749
    [No Abstract]   [Full Text] [Related]  

  • 7. [How do you want to die? The therapeutic options in ventricular tachyarrhythmia at the end of the anti-arrhythmia drug era].
    Seipel L
    Z Kardiol; 1995 Oct; 84(10):787-90. PubMed ID: 7502564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Invasive differential therapy of supraventricular and ventricular tachyarrhythmias].
    Perings C; Hennersdorf M; Klein RM; Vester EG; Strauer BE
    Internist (Berl); 1996 Jan; 37(1):60-73. PubMed ID: 8837829
    [No Abstract]   [Full Text] [Related]  

  • 9. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Hickey K; Curtis AB; Lancaster S; Larsen G; Warwick D; McAnulty J; Mitchell LB
    Am Heart J; 2001 Jul; 142(1):99-104. PubMed ID: 11431664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of outcome in patients with sustained ventricular tachyarrhythmias: the antiarrhythmics versus implantable defibrillators (AVID) study registry.
    Pinski SL; Yao Q; Epstein AE; Lancaster S; Greene HL; Pacifico A; Cook JR; Jadonath R; Marinchak RA
    Am Heart J; 2000 May; 139(5):804-13. PubMed ID: 10783213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the management of malignant ventricular tachyarrhythmias: the roles of drug therapy and implantable defibrillators.
    Kim SG
    Am Heart J; 1995 Nov; 130(5):1144-50. PubMed ID: 7484752
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ; Krahn A; Klein G
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
    Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
    Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable defibrillators in patients with coronary artery disease at high risk for ventricular arrhythmia.
    Uretsky BF
    N Engl J Med; 1997 Jun; 336(23):1677. PubMed ID: 9173277
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable Defibrillators.
    Naccarelli GV; Wolbrette DL; Dell'Orfano JT; Patel HM; Luck JC
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8):864-91. PubMed ID: 9727666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.